Tirzepatide is a safe and effective option for most people who are obese or overweight with one or more related health conditions
Biomedicines 10(7):1582 Rhea EM et al (2024) Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimers and Parkinsons diseases
Many users report that injecting on a completely empty stomach intensifies the initial wave of nausea
Key Study Findings During the 36-week, open label tirzepatide treatment period, mean weight loss was 21%, or approximately 22.5 kg/50 pounds
Someone reads about vitamin shots for energy, sees B12 lipotropic injections marketed as a fat solution, hears about NAD for energy, then wonders how any of it connects to a GLP-1 medication
27 kg/m2 or more - Corresponding to overweight